PodcastIntel
Sign in Get Started Free
HCPLive
HCPLive

Topical vs Oral JAK Inhibitors in Vitiligo, With Iltefat Hamzavi, MD

Oct 9, 2026 · 0:04:47
✨ AI Summary
  • JAK inhibitors have distinct roles for topical and oral vitiligo treatment.
  • Discussion from Fall Clinical Dermatology Conference 2026 highlighted takeaways.
  • Evolving role of JAK inhibitors in vitiligo management explored.

Guests on This Episode

More from HCPLive

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to HCPLive and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →